Dr Alok Raghav

About

Alok Raghav is a clinical researcher and academic scholar with advanced expertise in endocrinology, global health research, and translational medicine. He holds degrees in Endocrinology and has more than eight years of experience in clinical research, including randomized controlled trials, systematic reviews, observational studies, and interdisciplinary healthcare innovation. His research interests span diabetes mellitus, pancreatic cancer therapeutics, stroke management, nanomedicine, artificial intelligence in healthcare, and multiple long-term conditions (MLTCs).
Dr. Raghav has contributed to numerous research projects focused on improving patient-centered outcomes, healthcare economics, and evidence-based clinical decision-making. His work includes the development of the 3E Model (Education, Empowerment, and Economics) for Type 2 Diabetes Mellitus, targeted nanotherapeutic systems for pancreatic cancer, and AI-integrated diagnostic technologies. He is also actively involved in biomedical innovation, including sensor-assisted neurodiagnostic devices and translational healthcare technologies.
In addition to research, he has extensive experience in scientific writing, grant development, data analysis, and manuscript preparation using advanced statistical and systematic review tools such as SPSS, Origin, and Rayyan. Dr. Raghav has authored and reviewed multiple academic manuscripts and remains actively engaged in advancing interdisciplinary medical research with a focus on innovation, affordability, and global healthcare impact.

Employment

• Department of Biotechnology, Faculty of Engineering and Technology, Rama University, Rama City Associate Professor
  2026 - Present
• Gachon University - Medical Campus Research Professor
  2023 - Present
• GSVM Medical College Scientist C
  2019 - 2022
• IIT Kanpur Project Scientist
  2017 - 2019
• Indian Institute of Toxicology Research PROJECT ASSISTANT
  2011 - 2013

Education

• Aligarh Muslim University PhD Endocrinology
  2013 - 2016

Projects & Funding

Projects & funding information is unavailable.

Publications (12)

• Virtual Reality to Improve Breastfeeding Outcomes: A Systematic Review and Meta-Analysis
  Nursing Reports 2026 DOI: 10.3390/nursrep16060209
  +Save
• Phase I–IV Drug Trials on Hepatocellular Carcinoma in Asian Populations: A Systematic Review of Ten Years of Studies
  International Journal of Molecular Sciences 2024 DOI: 10.3390/ijms25179286
  +Save
• Glycated albumin as a surrogate marker for prediabetes: a cross-sectional study
  International Journal of Diabetes in Developing Countries 2024 DOI: 10.1007/s13410-023-01250-z
  +Save
• Evaluation of Micronutrients and Pro-Inflammatory Cytokines Levels in Nutritionally Deprived Children—A Tertiary Care Hospital-Based Study
  Nutrients 2023 DOI: 10.3390/nu15234865
  +Save
• Engineered Extracellular Vesicles in Treatment of Type 1 Diabetes Mellitus: A Prospective Review
  Biomedicines 2022 DOI: 10.3390/biomedicines10123042
  +Save
• Mesenchymal Stromal Cell-Derived Tailored Exosomes Treat Bacteria-Associated Diabetes Foot Ulcers: A Customized Approach From Bench to Bed.
  Frontiers in microbiology 2021 DOI: 10.3389/fmicb.2021.712588
  +Save
• Association of Circadian Clock and Severe Acute Respiratory Syndrome Coronavirus 2 Infection
  Chronobiology in Medicine 2021 DOI: 10.33069/cim.2021.0010
  +Save
• Prospective Role of N-Acetyl-5-Methoxytryptamine and 5-Hydroxytryptophan in β-Cell Health and Improved Insulin Sensitivity in Hyperglycemia
  Chronobiology in Medicine 2021 DOI: 10.33069/cim.2021.0001
  +Save
• Mesenchymal Stem Cell-Derived Exosomes Exhibit Promising Potential for Treating SARS-CoV-2-Infected Patients
  Cells 2021 DOI: 10.3390/cells10030587
  +Save
• TNF-α gene polymorphisms and risk of urinary bladder cancer – A case-control study and meta-analysis
  Meta Gene 2021 DOI: 10.1016/j.mgene.2020.100848
  +Save